Researchers accused of etanercept “bias”


A industry sponsored study published late last year in the New England Journal of Medicine has been accused of being biased in favour of the anti-TNF etanercept. In November last year Paul Emery and colleagues reported the results of the PRIZE trial, which suggested that for patients with early rheumatoid arthritis who achieved remission on ...


Already a member? Login to keep reading


OR
© 2017 the limbic